Preview

Медицинский алфавит

Расширенный поиск

Этиологические особенности ишемических инсультов в молодом возрасте

Полный текст:

Об авторе

Н. В. Пизова
ФГБОУ ВПО «Ярославский государственный медицинский университет» Минздрава России
Россия


Список литературы

1. Griffiths D, Sturm J. Epidemiology and etiology of young stroke. Stroke Res Treat 2011; 2011: 1-9.

2. Moran GM, Fletcher B, Feltham MG, Calvert M, Sackley C, Marshall T. Fatigue, psychological and cognitive impairment following transient ischaemic attack and minor stroke: a systematic review. Eur J Neurol. 2014;21:1258-1267.

3. Volonghi I, Pendlebury ST, Welch SJ, Mehta Z, Rothwell PM. Cognitive outcomes after acute coronary syndrome: a population based comparison with transient ischaemic attack and minor stroke. Heart. 2013; 99: 1509-1514.

4. Ramirez L, Kim-Tenser MA, Sanossian N, Cen S, Wen G, He S, et al. Trends in acute ischemic stroke hospitalizations in the United States. J Am Heart Assoc (2016) 510.1161/ JAHA.116.003233.

5. Béjot Y, Delpont B, Giroud M. Rising stroke incidence in young adults: more epidemiological evidence, more questions to be answered. J Am Heart Assoc (2016) 510.1161/ JAHA.116.003661.

6. Tibaek M, Dehlendorff C, Jorgensen HS, Forchhammer HB, Johnsen SP, Kammersgaard LP. Increasing incidence of hospitalization for stroke and transient ischemic attack in young adults: a registry-based study. J Am Heart Assoc (2016) 510.1161/JAHA. 115.003158.

7. de los Rios RF, Kleindorfer DO, Khoury J, Broderick JP, Moomaw CJ, Adeoye O, Flaherty ML Khatri P, Woo D, Alwell K, Eilerman J, Ferioli S, Kissela BM. Trends in substance abuse preceding stroke among young adults: a population-based study. Slroke. 2012; 43:3179-3183.

8. Thijs V, Grittner U, Dichgans M, Enzinger C, Fazekas F, Giese AK, Kessler C, Kolodny E, Kropp P, Martus P, Norrving B, Ringelstein EB, f Медицинский алфавит № 1 / 201 Rothwell PM, Schmidt R2, Tanislav C, Tatlisumak T, von Sarnowski B, Rolfs A; Stroke in Fabry Investigators. Family History in Young Patients With Stroke. Stroke. 2015 Jul; 46 (7): 1975-8.

9. Пизова Н. В., Дмитриев А. Н., Дружинин Д. С., Чижов П. А., Табаков В. Синдром недифференцированной дисплазии соединительной ткани. Журнал неврологии и психиатрии им. С. С. Корсакова. 2012; 112 (6): 4-7.

10. Rodés-Cabau J, Noël M, Marrero A, et al. Atherosclerotic burden findings in young cryptogenic stroke patients with and without a patent foramen ovale. Stroke 2009; 40: 419-425.

11. Sacco RL, Ellenberg JH, Mohr JP, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989; 25: 382-390.

12. Ankolekar S, Rewell S, Howells DW, et al. The influence of stroke risk factors and comorbidities on assessment of stroke therapies in humans and animals. Int J Stroke 2012; 7: 386-397.

13. Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association / American Stroke Association. Stroke 2011; 42: 517-584.

14. Bousser MG. Stroke prevention: an update. Front Med 2012; 6: 22-34.

15. Tan KS, Tan CT, Churilov L, et al. Ischemic stroke in young adults: a comparative study between Malaysia and Australia. Neurology Asia 2010; 15: 1-9.

16. Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke. 1993; 24 (1): 35-41. DOI: http://dx.doi.org/10.1161/01.STR.24.L35.

17. Пизова Н. В. Заболевания сердца и инсульты у лиц молодого возраста. Неврология, нейропсихиатрия, психосоматика 2014; 2: 62-69.

18. Hagan PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Prac 1984; 59: 17-20.

19. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-controlstudies. Neurology2000; 55:1172-9.

20. Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988; 318: 1148-52.

21. Berthet K Lavergne T, Cohen A, et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke 2000; 31: 398-403.

22. Homma S, Sacco RL, Di Tullio MR, et al. Effect of medical treatment in stroke patients with patent foramen ovale. Patent Foramen Ovale in Cryptogenic Stroke Study Circulation 2002; 105: 2625-2631.

23. Bogousslavsky J, Garazi S, Jeanrenaud X, et al. Stroke recurrence in patients with patent foramen ovalethe Lausanne Study. Lausanne Stroke with Paradoxal Embolism Study Group. Neurology 1996; 46: 1301-1305.

24. Nedeltchev K, Arnold M, Wahl A, et al. Outcome of patients with cryptogenic stroke and patent foramen ovale J Neurol Neurosurg Psychiatry 2002; 72: 347-350.

25. Rosenberg RD, Aird WC. Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med. 1999; 340: 1555-1564.

26. Kistler JP, Furie KL. Patent foramen ovale diameter and embolic stroke: a part of the puzzle? Am J Med. 2000; 109: 506-507.

27. Насонов Е.Л. Васкулиты и васкулопатии / Е.Л. Насонов, А. А. Баранов, Н. П. Шилкина. - Ярославль: Верхняя Волга, 1999.- 616 с. , том № 1 Неврология и психиатрия

28. Aortitis and aortic aneurysm in systemic vasculitis / A. Garcia-Martinez, S. Prieto-Gonzalez, P. Arguuis [et al.] // Etiology, Pathogenesis and Pathophysiology of Aortic Aneurysms and Aneurysm Rupture / Ed. by Grundmann R.T.- InTech, 2011. - Ch. 8. - P. 137-158.

29. Gonzalez-Gay M. Systemic vasculitides / M. Gonzalez-Gay, C. Garcia-Porrua // Best Practice & Research Clin. Rheum.-2002.-Vol. 16, № 5.-P. 833-845. 10. Guideline for management of vasculitis syndrome (JCS2008) // Circ. J. - 2011. - Vol. 75. - P. 474-503.

30. Guillevin L. Vasculitis: mechanisms involved and clinical manifestations / L. Guillevin, T. Dorner // Arth. Res. and Ther.-2007. - № 9, Suppl. 2. - P. S 9- S 18.

31. Watts R. Vasculitis in Clinical Practice / R. Watts, D. Scott. - Springer, 2010.- 198 р.

32. Rasmussen N. The 2012 revised international Chapel Hill Consensus Conference namenclature of the vasculitides / N. Rasmussen // Ann. Rheum. Dis. - 2012.- Vol. 71, Suppl. 3. - P. 16.

33. Kim H. J., Suh D. C., Kim J. K et al. Correlation of neurological manifestations of Takayasu's arteritis with cerebral angiographic findings. Clin. Imaging. 2005; 29: 79-85.

34. Ringleb P. A., Strittmatter E.I., Loewer M. et al. Cerebrovascular manifestations of Takayasu arteritis in Europe. Rheumatology (Oxford). 2005; 44: 1012-15.

35. Ureten K., Ozturk M. A., Onat A.M. et al. Takayasu’s arteritis: results of a university hospital of 45 patients in Turkey. Int J Cardiol. 2004; 96: 259-64.

36. Klos K., Flemming K. D., Petty G. W., Luthra H. S. Takayasu’s arteritis with arteriographic evidence of intracranial vessel involvement. Neurology. 2003; 60: 1550-1.

37. Maksimowicz-McKinnon K., Clark T.M., Hoffman G. S. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum. 2007; 56: 1000-9.

38. Hwang J., Kim S. K., Bang O. Y. et al. Ischemic Stroke in Takayasu’s Arteritis: Lession Patterns and Possible Mechanisms. J Clin Neurol. 2012; 8:109-15.

39. Пизова Н. В. Неврологические и психические расстройства при системной красной волчанке. Журнал неврол и психиат. им. С. С. Корсакова. 2010; 8: 76-83.

40. Cervera R., Khamashta M. A., Font J. et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore). 2003; 82: 299-308.

41. Ainiala H., Hietaharju A., Loukkola J. et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum. 2001;45: 419-23.

42. Brey R. L., Holliday S. L, Saklad A. R. et al. Neuropsychiatric syndromes in lupus. Prevalence using standardized definitions. Neurology. 2002; 58: 1214-20.

43. Futrell N, Millikan C. Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus. Stroke. 1989;20(5):583-91.

44. Krishnan E. Stroke subtypes among young patients with systemic lupus erythematosus. Am J Med. 2005; 118: 1415.

45. Ward M.M. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum. 1999; 42: 338-46.

46. Bessant R., Duncan R., Ambler G. et al. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: a case-control study. Arthritis Rheum. 2006; 55: 892-9.

47. Booth S., Chohan S., Curran J. C. et al. Whole blood viscosity and arterial thrombotic events in patients with systemic lupus erythematosus. Arthritis Rheum. 2007; 57: 845-50.

48. Gonzales-Portillo F., McIntyre J.A., Wagenknecht D. R. et al. Spectrum of antiphospholipid antibodies (aPL) in patients with cerebrovascular disease. J Stroke Cerebrovasc Dis. 2001; 10: 222-6.

49. Blohorn A., Guegan-Massardier E., Triquenot A. et al. Antiphospholipid antibodies in the acute phase of cerebral ischaemia in young adults: a descriptive study of 139 patients. Cerebrovasc Dis. 2002; 13: 156-62.

50. Jennekens F. G.I., Kater L. The central nervous system in systemic lupus erythematosus. Part

51. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology. 2002; 41: 619-30.

52. Goel D, Reddy SR, Sundaram C, Prayaga AK, Rajasekhar L Narsimulu G. Active necrotizing cerebral vasculitis in systemic lupus erythematosus. Neuropathology. 2007; 27: 561-5.

53. Conen KL Jeanneret C, Hecker B, Cathomas G, Biedermann BC. Acute occlusive large vessel disease leading to fatal stroke in a patient with systemic lupus erythematosus: Arteritis or atherosclerosis? Arthritis Rheum. 2006; 54: 908-13.

54. Mikdashi J., Handwerger B., Langenberg P. et al. Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemicstroke and stroke severity in systemic lupus erythematosus. Stroke. 2007; 38 (2): 281-5.

55. Benjamin L. A. HIV, antiretroviral treatment, hypertension, and stroke in Malawian adults: A case-control study / Benjamin L. A., Corbett E. L, Connor M. D. et al. // Neurology.- 2016, Jan 26. - 86 (4). - 324-33.

56. Шеломов А. С. Оппортунистические заболевания как причины поражения центральной нервной системы у больных ВИЧ-инфекцией / А. С. Шеломов, Е. В. Степанова, О. Н. Леонова, Н.А. Смирнова // Журн. инфектологии. - 2016. - 3 (8).- 107-115.

57. Иванова М. Ф., Евтушенко С. К. с соавт. Ранняя диагностика ВИЧ-ассоциированных неврологических нарушений как актуальная проблема в практике невролога / М. Ф. Иванова, С. К. Евтушенко, А. В. Семенова и др. // Междун. неврол. журн.- 2016. - 8 (86). - 53-62.

58. Трофимова Т. Н. Многоликая нейрорадиология ВИЧ-инфекции / Т. Н. Трофимова, H. А. Беляков // Лучевая диагностика и терапия.- 2010. - 3 (I).-3-11.

59. Цинзерлинг В. А. Поражения центральной нервной системы при ВИЧ-инфекции // ВИЧ-инфекция и иммуносупрессии.- 20I4.- I (6).- 40-45.

60. Трофимова Т. Н. Поражения головного мозга у ВИЧ-инфицированных пациентов. Клинико-лабораторные и радиологические сопоставления / Т. Н. Трофимова, Е. Г. Багулина, В. В. Рассохин, Н. А. Беляков // Мед. академ. журн. - 20I5. - 4 (I5). - 3I-37.

61. Yen Y. F., Jen I., Chen M., Chuang P. H., Liu Y. L, Sharp G. B., Chen Y. M. Association of Cytomegalovirus End-Organ Disease with Stroke in People Living with HIV/AIDS: A Nationwide Population-Based Cohort Study // J. PLoS One. - 20I6.- II (3). - 0I5I684.

62. Бартлетт Д. Клинические аспекты ВИЧ-инфекции / Д Бартлетт, Д. Галант, П. Фам.- М.: Р. Валент, 20I2.- 528 с.

63. Alexander M. B. Iron deficiency anemia, thrombocytosis, and cerebrovascular accident. Southern Medical Journal. 1983; 76 (5): 662-663. doi: I0.I097/000076II-I98305000-00035.

64. Chang Y.-L., Hung S.-H., Ling W., Lin H.-C., Li H.-C., Chung S.-D. Association between ischemic stroke and iron-deficiency anemia: A Population-based Study. PLOS ONE. 20I3; 8 (I2) doi: I0.I37I/journal.pone.0082952. e82952. 6-4. Killip S., Bennett J. M., Chambers M. D. Iron deficiency anemia. American Family Physician. 2007;75 (5): 67I-678.

65. Knizley H., Noyes W. D. Iron deficiency anemia, papilledema, thrombocytosis, and transient hemiparesis. Archives of Internal Medicine. I972; I29 (3): 483^86. doi: I0.I00I/ archinte.I972.00320030I030I3.

66. Maguire J. L, Deveber G., Parkin P. C. Association between iron-deficiency anemia and stroke in young children. Pediatrics. 2007; I20 (5): I053-I057. doi: I0.I542/peds.2007-0502.

67. Hartfield D.S., Lowry N.J., Keene D. L., Yager J. Y. Iron deficiency: a cause of stroke in infants and children. Pediatric Neurology. I997; I6 (I): 50-53. doi: I0.I0I6/s0887-8994(96)00290-1.

68. Akins P. T., Glenn S., Nemeth P. M., Derdeyn C. P. Carotid artery thrombus associated with severe iron-deficiency anemia and thrombocytosis. Stroke. I996;27(5): I002-I005. doi: I0.II6I/0I.STR.27.5.I002.

69. Batur Caglayan H. Z., Nazliel B., Irkec C., Dumlu A., Filiz A., Panpalli Ates M. Iron-deficiency anemia leading to transient ischemic attacks due to intraluminal carotid artery thrombus. Case Reports in Neurological Medicine. 20I3;20I3:3. doi: I0. II55/20I3/8I34I5.8I34I5.

70. Nakamizo T., Ishikawa K., Amari K. Simultaneous thrombosis in a normal left ventricle and normal carotid artery in a patient with a stroke secondary to iron deficiency anemia. Journal of Medical Cases. 20I4; 5 (6): 35I-354. doi: I0.I4740/jmcI786w.

71. Mehta P.J., Chapman S., Jayam-Trouth A., Kurukumbi M. Acute ischemic stroke secondary to iron deficiency anemia: a case report. Case Reports in Neurological Medicine. 20I2; 20I2: 5. doi: I0.II55/20I2/487080.487080.

72. Gopalratnam K, Woodson KA, Rangunwala J, Sena K, Gupta M. A Rare Case of Stroke Secondary to Iron Deficiency Anemia in a Young Female Patient. Case Rep Med. 20I7; 20I7: I68463I. doi: I0.II55/20I7/I68463I.

73. Furie B, Furie BC. Mechanisms of disease: Mechanisms of thrombus formation. New England Journal of Medicine. 2008; 359 (9): 938-49.

74. Borissoff JI, Spronk HMH, ten Cate H. Mechanisms of Disease the Hemostatic System As A Modulator of Atherosclerosis. New England Journal of Medicine. 20II; 364 (I8): I746-60.

75. Loeffen R, Spronk HM, ten Cate H. The impact of blood coagulability on atherosclerosis and cardiovascular disease. J Thromb Haemost. 20I2; I0 (7): I207-I6.

76. Lippi G, Franchini M, Targher G. Arterial thrombus formation in cardiovascular disease. Nat Rev Cardiol. 20II; 8 (9): 502-I2.

77. Marlar R. Report on the diagnosis and treatment of homozygous protein C deficiency. Report of the Working Party on Homozygous Protein C Deficiency of the ICTH-Subcommittee on Protein C and Protein S. Thromb. Haemost. I989; 6I: 529-53I.

78. Boekholdt SM, Kramer MH. Arterial thrombosis and the role of thrombophilia. Semin Thromb Hemost. 2007; 33 (6): 588-96.

79. Козловская Н. Л. Тромбофилические состояния. Клинич. фармакология и терапия. 2003; I2 (I): 74-9.

80. Пизова Н. В. Наследственные тромбофилии и инсульт. Журн. неврологии и психиатрии им. С. С. Корсакова, 20I3: 8 (II3): 76-8I.

81. Патрушев Л. И. Генетические механизмы наследственных нарушений гемостаза. Биохимия. 2002; 67: 40-55.

82. Решетняк Т. М., Патрушев Л. И., Стукачева Е.А. и др. Мутации Leiden, G202I0A в гене протромбина и антифосфолипилные антитела при системной красной волчанке и антифосфолипидном синдроме. Тер. архив. 2000; 5: 34-38.

83. Owen W. G., Esmon C. T. Functional properties of an endothelial cofactor for thrombin_catalized activation of protein C. J. Biol. Chem. I98I; 256: 5532-5535.

84. Dahlback B. Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood. 2008; II2 (I): I9-27.

85. Bonduel M., Sciuccati G., Hepner M. et al. Prethrombotic disorders in children with arterial ischemic stroke and sinovenous thrombosis. Arch Neurol. I999; 56: 967-7I.

86. Szolnoki Z., Somogyvari F., Kondacs A. et al. Evaluation of the roles of the Leiden V mutation and ACE I/D polymorphism in subtypes of ischemic stroke. J. Neurol. 200I; 248 (9): 756-6I.

87. Ridker P. M., Hennekens C.H., Stampfer M.J. et al. Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet. I994; 343 (8903): 940-3.

88. Smith F. B., Lee A. J., Fowkes F. G. et al. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol. I997; I7 (II): 332I-5.

89. Munts A. G., van Genderen P. J., Dippel D. W. et al. Coagulation disorders in young adults with acute cerebral ischaemia. J Neurol. I998; 245 (I): 2I-5.

90. Kenet G., Sadetzki S., Murad H. et al. Factor V leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke. 2000; 3I: I283-8.

91. Moster M. Coagulopathies and arterial stroke. Journal of Neuro-Ophthalmology. 2003; 23 (I): 63-7I-3.

92. Lane T. R., Shalhoub J., Perera R., Mehta A., Ellis M. R., Sandison A. Diagnosis and surgical management of free-floating thrombus within the carotid artery. Vasc. Endovasc. Surg. 20I0; 44 (7): 586-593.

93. Bhatti A.F., Leon L.R., Labropoulos N., Rubinas T. L., Rodriguez H., Kalman P. G., et al. I. Free-floating thrombus of the carotid artery: literature review and case reports. J. Vasc. Surg. 2007; 45 (I): I99-205.

94. Chua H. C., Lim T., Teo B. C., Phua Z., Eng J. Free-floating thrombus of the carotid artery detected on carotid ultrasound in patients with cerebral infarcts: a I0-year study. Ann. Acad. Med. Singapore. 20I2; 4I (9): 420-424.

95. Mutlu G. M., Green D., Bellmeyer A., Baker C. M., Burgess Z., Rajamannan N. Ambient particulate matter accelerates coagulation via an IL-6-dependent pathway. J. Clin. Invest. 2007; II7 (I0): 2952-296I.

96. Marchi R., Walton B. L., McGary C.S., Lin F.-C., Ma A. D., Pawlinski R. Dysregulated coagulation associated with hypofibrinogenemia and plasma hypercoagulability: implications for identifying coagulopathic mechanisms in humans. Thromb. Haemost. 20I2; I08 (3): 5I6.

97. Гусев Е. И., Скворцова В. И. Ишемия головного мозга. М., 200I. 327 c.

98. Пизова Н. В., Соколов М. А., Измайлов И. А. Целлекс в лечении больных с острым нарушением мозгового кровообращения: результаты российского многоцентрового сравнительного открытого клинического исследования. Журнал неврологии и психиатрии им. С. С. Корсакова 20I4; 5: 22-26.

99. Бельская Г. Н., Пизова Н. В., Соколов М. А., Измайлов И. А. Влияние нейропротективной терапии на течение церебрального инсульта. Медицинский совет. 20I6. № II. С. 26-3I.


Для цитирования:


Пизова Н.В. Этиологические особенности ишемических инсультов в молодом возрасте. Медицинский алфавит. 2018;1(1):36-44.

For citation:


Pizova N.V. Etiological features of ischemic strokes at young age. Medical alphabet. 2018;1(1):36-44. (In Russ.)

Просмотров: 43


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2078-5631 (Print)